Modulation of cIAP-1 by Novel Antitubulin Agents When Combined with Bryostatin 1 Results in Increased Apoptosis in the Human Early Pre-B Acute Lymphoblastic Leukemia Cell Line Reh
- 9 December 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 266 (1) , 76-80
- https://doi.org/10.1006/bbrc.1999.1768
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, RehLeukemia Research, 1999
- Molecular Genetics of Childhood LeukemiasJournal of Pediatric Hematology/Oncology, 1998
- Apoptosis Meets Signal Transduction: Elimination of a BAD InfluenceCell, 1996
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995
- Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell deathCell, 1995
- Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xLNature, 1995
- High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosisAnnals of Hematology, 1994
- Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell linesAnnals of Oncology, 1994
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985
- A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.Proceedings of the National Academy of Sciences, 1984